A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)

International journal of biological macromolecules 2021

Esculentoside A rescues granulosa cell apoptosis and folliculogenesis in mice with premature ovarian failure

Aging 2020

Esculentoside A specifically binds to ribosomal protein S3a and impairs LPS-induced signaling in macrophages

International immunopharmacology 2018

Esculentoside A suppresses lipopolysaccharide-induced pro-inflammatory molecule production partially by casein kinase 2

Journal of ethnopharmacology 2017

Esculentoside A ameliorates cecal ligation and puncture-induced acute kidney injury in rats

Experimental animals 2017